Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism
Status:
Unknown status
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
Pilot randomized study of the sidlenafil efficacy in combination with oral anticoagulants in
the treatment of patients with intermediate-high risk of pulmonary embolism
Phase:
Phase 1
Details
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation